Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients
Autor: | Xueling Wang, Juanjuan Liu, Honghua Zhu, Dongqing Wang, Juan Jiang, Le Kang |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Cancer Research medicine.medical_specialty endocrine system diseases Gastroenterology 03 medical and health sciences 0302 clinical medicine Immunology and Microbiology (miscellaneous) Internal medicine Diabetes mellitus Hyperlipidemia medicine Chemerin Family history fatty acid-binding protein 4 Pregnancy biology Receiver operating characteristic business.industry nutritional and metabolic diseases General Medicine Articles medicine.disease peripheral blood Molecular medicine gestational diabetes mellitus Gestational diabetes 030104 developmental biology 030220 oncology & carcinogenesis biology.protein business chemerin |
Zdroj: | Experimental and Therapeutic Medicine |
ISSN: | 1792-0981 |
Popis: | Expression and correlation of Chemerin and fatty acid-binding protein 4 (FABP4) in peripheral blood of gestational diabetes mellitus (GDM) patients were investigated. Sixty patients with GDM from March 2018 to March 2019 in the People's Hospital of Zhangqiu Area were selected as the study group (SG) and another 50 healthy pregnant women corresponding to their age and pregnancy were selected as the control group (CG). Enzyme linked immunosorbent assay (ELISA) was used to detect the expression of Chemerin and FABP4 in serum. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of Chemerin and FABP4 in peripheral blood for GDM patients. Pearson's correlation coefficient was used to analyze the correlation between Chemerin and FABP4 and the correlation between Chemerin and inflammatory factors such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Expression of Chemerin and FABP4 in peripheral blood of GDM patients were significantly higher than those in CG. The AUC of GDM patients diagnosed with Chemerin and FABP4 in peripheral blood was 0.820 and 0.814, while the AUC of GDM patients diagnosed with Chemerin combined with FABP4 in peripheral blood was 0.904. Expression of inflammatory factors IL-6 and TNF-α in the SG were significantly higher than those in the CG. Chemerin in the SG was positively correlated with FABP4 and positively correlated with inflammatory factors IL-6 and TNF-α. Patients with advanced age (≥35 years), family history of diabetes, hyperlipidemia, high pre-pregnancy BMI, high fasting blood glucose, high Chemerin and high FABP4 expression have high risk of GDM. In conclusion, Chemerin and FABP4 were upregulated in the peripheral blood of GDM patients. There was a positive correlation between the two and a positive correlation with the inflammatory factors IL-6 and TNF-α. |
Databáze: | OpenAIRE |
Externí odkaz: |